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Developing Service Delivery Measures
for Studies of Practice Variation:
The MPROVE Study
Glen Mays, PhD, MPH
University of Kentucky

AcademyHealth Public Health Systems Research Interest Group Meeting • Orlando, FL • 27 June 2012

Down
the briar
patch
we go…

Multi-Network Practice and Outcome
Variation Examination Study (MPROVE)

• Identify service delivery measures for selected, high-value
public health services
• Create a registry of measures collected consistently across
local communities
• Profile geographic variation in the delivery of selected public
health services across local communities
• Decompose variation into attributable components:
– need-sensitive or preference-sensitive factors
– supply-sensitive factors
• Examine associations between service delivery & outcomes
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Participating MPROVE networks
State
Local
Academic
Network Agencies Agencies* Units
Other

Total

Lead
Institution

CO

1

55

2

15

73

Association

FL

1

67

3

3

74

Local agency

MN

1

75

1

1

78

State agency

WA

1

36

2

1

40

Local agency

NJ

1

100

2

1

104

Academic

TN

1

16

2

1

20

Academic

Total

6

349

12

22

389
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Overview of Activities and Timeline
Phase II

Phase I
• Selection and specification
of “core” measures to collect
across networks
• Selection and specification
of additional “local”
measures to collect within
networks
• Development of analysis
plans

May
2012

• Data collection
• Pooling data across
networks

October
2012

Phase III
• Data analysis
• Within network
• Across networks
• Interpretation and
translation
• Development of initial
dissemination products
• Planning for future &
follow-up studies

April
2013

5

September
2013

MPROVE Measure Domains
• Communicable disease control
• Chronic disease prevention
• Environmental health protection
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MPROVE Measure Selection & Specification
•
•
•
•
•
•
•
•

Call for measures to identify inventory of candidate measures
Literature review to identify candidate measures
Delphi expert rating of measures based on selection criteria
Value of Information (VOI) analysis of first-tier measures
Discussion and modification of ratings
Final selection of “core” measures
Development of measure specifications
Final approval of measure specifications
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MPROVE Measurement Dimensions
• Availability/scope: are selected services/activities produced or
performed by the public health agency or delivery system
• Volume/intensity: absolute or relative frequency of service
delivery over a given unit of time
• Capacity: ratio of inputs to size of the relevant target
population or risk (e.g. sanitarians per 1000 septic tanks, food
safety inspectors per 1000 licensed food vendors)
• Reach: percent of the target population reached by the activity
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MPROVE Measurement Dimensions
• Quality-Appropriateness: Does the public health agency
and/or system act based on objectively measured health
needs and risk profiles of the population served? What is the
degree of concordance between a community’s documented
health needs/risks and the scope of public health activities
performed by the public health agency or the system as a
whole?
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MPROVE Measurement Dimensions
• Quality-Effectiveness/Fidelity: Does the public health agency
and/or system implement its activities based on available scientific
knowledge and fidelity to evidence-based guidelines? To what
extent are programs and services concordant with evidence-based
guidelines and professional consensus standards?
• Quality-Timeliness: Are public health activities implemented at the
appropriate points in time to maximize health protection and
minimize the risk of disease transmission or injury?
• Quality-Community Centeredness/Engagement: To what extent are
relevant stakeholders engaged in planning, priority-setting,
selection, and implementation of public health activities undertaken
by the public health agency and/or system? To what extent are
public health activities tailored appropriately to at-risk population
groups based on the groups’ values, preferences, needs, knowledge,
skills, and resources?
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MPROVE Measurement Dimensions
• Quality-Efficiency: To what extent are public health activities
implemented in ways that optimize the use of financial and
human resources? To what extent do implementation
processes avoid waste and delays in service? To what extent
do the benefits of public health activities justify their costs?
• Quality-Equity: Are there disparities in the reach of public
health activities to different population sub-groups defined by
personal characteristics such as race, ethnicity, geography, or
socio-economic status? Are there disparities in effectiveness,
timeliness, community-centeredness, and/or efficiency?
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MPROVE Measurement Dimensions
HHS Quality Aims*

Measurement Dimensions

Population-centered

Community-centered

Equitable

Equity

Proactive

Timeliness

Health-promoting

Effectiveness/fidelity

Risk-reducing

Effectiveness/fidelity

Vigilant

Appropriateness

Effective

Effectiveness/fidelity

Efficient

Efficiency

*Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services.
Priority Areas for the Improvement of Quality in Public Health. The Public Health Quality Forum.
Washington, D.C.: U.S. Department of Health and Human Services; 2010.
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Selection Criteria
• Domain: Degree to which the measure falls within one of the
three core domains of activity for this study: communicable
disease control; chronic disease prevention; environmental
health protection
• Dimension: Degree to which the measure addresses one or
more of the key dimensions of service delivery for this study:
availability, volume/intensity, capacity, reach, and/or quality.
• Relevance/Control: Degree to which the measure reflects an
activity that local public health agencies and/or their partners
have the authority (law) and organizational responsibility
(mission) to implement
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Selection Criteria
• Expected Health Impact: Degree to which improvements in
the measured activity are expected to result in improvements
in population health.
• Expected Economic Impact: Degree to which changes in the
measured activity are expected to result in changes in the cost
of delivering public health services, changes in the cost of
delivering other health care or social services (spill over),
and/or other changes in the direct and indirect costs of
preventable illness/injury/disability.
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Selection Criteria
• Expected Variation: Degree to which the measured activity is expected to
vary across local public health settings, vary across states/PBRN networks,
and vary over time.
• Feasibility: Degree to which it is economically and logistically feasible to
obtain the data needed to construct the measure at the level of the local
public health practice setting for all/most/many practice settings in each
participating PBRN.
• Expected Validity: Degree to which the measure characterizes the public
health activity of interest.
• Expected Reliability: Degree to which the measure characterizes the
activity consistently across different local public health settings and over
time
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Selecting Measures Based on Expected
Health Impact: a VOI Approach
• Proportion of the population currently exposed to the risk
factor(s) addressed by the measured activity [risk exposure]
• Proportion of the exposed population that is expected to be
reached by the measured activity [expected reach]
• Relative risk of the health outcome(s) comparing the exposed
to the unexposed population [preventable fraction]
• Relative risk of the health outcome(s) comparing the
population reached by the measured activity to the population
not reached [efficacy]
AL Siu, EA McGlynn, et al. 1992
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Example VOI Calculation
• Activity to Measure: Community-wide campaigns to increase physical
activity, rated as “Strong Evidence of Effectiveness” in Community Guide
• Risk Exposure (Adults): 64% failure to receive recommended PA dose
• Preventable fraction: 24% reduction in premature mortality
• Efficacy: median net improvement of 4% in receipt of recommended PA
• Expected Reach: 30%
• Impact fraction: expected proportional reduction in the outcome
attributable to improvement of the measured activity

= 0.64 * 0.30 * 0.04 * 0.24
= 0.00184

Task Force on Community Preventive Services. Recommendations
to increase physical activity in
17
communities. Am J Prev Med 2002;22 (4S):67-72.

Conclusions
• Test the utility of the PBRN model for standardized
measurement, data collection, and analysis
• Select “high value” measures to improve rigor and relevance
of research
• Use geographic variation studies for hypothesis generation,
QI targeting, cost studies, natural experiments, theory-driven
sampling frames
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